These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33111257)

  • 1. Antagonism of Protease-Activated Receptor 4 Protects Against Traumatic Brain Injury by Suppressing Neuroinflammation via Inhibition of Tab2/NF-κB Signaling.
    Luo J; Wu X; Liu H; Cui W; Guo W; Guo K; Guo H; Tao K; Li F; Shi Y; Feng D; Yan H; Gao G; Qu Y
    Neurosci Bull; 2021 Feb; 37(2):242-254. PubMed ID: 33111257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet protease-activated receptor (PAR)4, but not PAR1, associated with neutral sphingomyelinase responsible for thrombin-stimulated ceramide-NF-κB signaling in human platelets.
    Chen WF; Lee JJ; Chang CC; Lin KH; Wang SH; Sheu JR
    Haematologica; 2013 May; 98(5):793-801. PubMed ID: 23065519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contributions of Protease-Activated Receptors PAR1 and PAR4 to Thrombin-Induced GPIIbIIIa Activation in Human Platelets.
    Duvernay MT; Temple KJ; Maeng JG; Blobaum AL; Stauffer SR; Lindsley CW; Hamm HE
    Mol Pharmacol; 2017 Jan; 91(1):39-47. PubMed ID: 27784794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin.
    Kahn ML; Nakanishi-Matsui M; Shapiro MJ; Ishihara H; Coughlin SR
    J Clin Invest; 1999 Mar; 103(6):879-87. PubMed ID: 10079109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking protease-activated receptor 4 alleviates liver injury induced by brain death.
    Fang H; Yuan Z; Zhu Y; Tang H; Pang C; Li J; Shi J; Guo W; Zhang S
    Biochem Biophys Res Commun; 2022 Mar; 595():47-53. PubMed ID: 35093640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ATP-gated P2X1 receptor plays a pivotal role in activation of aspirin-treated platelets by thrombin and epinephrine.
    Grenegård M; Vretenbrant-Oberg K; Nylander M; Désilets S; Lindström EG; Larsson A; Ramström I; Ramström S; Lindahl TL
    J Biol Chem; 2008 Jul; 283(27):18493-504. PubMed ID: 18480058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAR1 antagonists inhibit thrombin-induced platelet activation whilst leaving the PAR4-mediated response intact.
    Judge HM; Jennings LK; Moliterno DJ; Hord E; Ecob R; Tricoci P; Rorick T; Kotha J; Storey RF
    Platelets; 2015; 26(3):236-42. PubMed ID: 24750101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium mobilization and protein kinase C activation downstream of protease activated receptor 4 (PAR4) is negatively regulated by PAR3 in mouse platelets.
    Arachiche A; de la Fuente M; Nieman MT
    PLoS One; 2013; 8(2):e55740. PubMed ID: 23405206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of protease-activated receptor 4 impairs platelet procoagulant activity during thrombus formation in human blood.
    French SL; Arthur JF; Lee H; Nesbitt WS; Andrews RK; Gardiner EE; Hamilton JR
    J Thromb Haemost; 2016 Aug; 14(8):1642-54. PubMed ID: 26878340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin-induced platelet PAR4 activation: role of glycoprotein Ib and ADP.
    Adam F; Verbeuren TJ; Fauchère JL; Guillin MC; Jandrot-Perrus M
    J Thromb Haemost; 2003 Apr; 1(4):798-804. PubMed ID: 12871418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin receptor PAR4 drives canonical NLRP3 inflammasome signaling in the heart.
    Fender AC; Kleeschulte S; Stolte S; Leineweber K; Kamler M; Bode J; Li N; Dobrev D
    Basic Res Cardiol; 2020 Jan; 115(2):10. PubMed ID: 31912235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking the protease-activated receptor 1-4 heterodimer in platelet-mediated thrombosis.
    Leger AJ; Jacques SL; Badar J; Kaneider NC; Derian CK; Andrade-Gordon P; Covic L; Kuliopulos A
    Circulation; 2006 Mar; 113(9):1244-54. PubMed ID: 16505172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease-activated receptors 1 and 4 are shut off with distinct kinetics after activation by thrombin.
    Shapiro MJ; Weiss EJ; Faruqi TR; Coughlin SR
    J Biol Chem; 2000 Aug; 275(33):25216-21. PubMed ID: 10837487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleeding.
    Wong PC; Seiffert D; Bird JE; Watson CA; Bostwick JS; Giancarli M; Allegretto N; Hua J; Harden D; Guay J; Callejo M; Miller MM; Lawrence RM; Banville J; Guy J; Maxwell BD; Priestley ES; Marinier A; Wexler RR; Bouvier M; Gordon DA; Schumacher WA; Yang J
    Sci Transl Med; 2017 Jan; 9(371):. PubMed ID: 28053157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAR4 (Protease-Activated Receptor 4) Antagonism With BMS-986120 Inhibits Human Ex Vivo Thrombus Formation.
    Wilson SJ; Ismat FA; Wang Z; Cerra M; Narayan H; Raftis J; Gray TJ; Connell S; Garonzik S; Ma X; Yang J; Newby DE
    Arterioscler Thromb Vasc Biol; 2018 Feb; 38(2):448-456. PubMed ID: 29269513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phillyrin protects mice from traumatic brain injury by inhibiting the inflammation of microglia via PPARγ signaling pathway.
    Jiang Q; Chen J; Long X; Yao X; Zou X; Yang Y; Huang G; Zhang H
    Int Immunopharmacol; 2020 Feb; 79():106083. PubMed ID: 31923823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development.
    Vretenbrant K; Ramström S; Bjerke M; Lindahl TL
    Thromb Haemost; 2007 Mar; 97(3):417-24. PubMed ID: 17334509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen Attenuates Traumatic Brain Injury by Inhibiting the Activation of Microglia and Astrocyte-Mediated Neuroinflammatory Responses.
    Wang J; Hou Y; Zhang L; Liu M; Zhao J; Zhang Z; Ma Y; Hou W
    Mol Neurobiol; 2021 Mar; 58(3):1052-1061. PubMed ID: 33085047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-function analysis of protease-activated receptor 4 tethered ligand peptides. Determinants of specificity and utility in assays of receptor function.
    Faruqi TR; Weiss EJ; Shapiro MJ; Huang W; Coughlin SR
    J Biol Chem; 2000 Jun; 275(26):19728-34. PubMed ID: 10779527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease-activated Receptor-4 Signaling and Trafficking Is Regulated by the Clathrin Adaptor Protein Complex-2 Independent of β-Arrestins.
    Smith TH; Coronel LJ; Li JG; Dores MR; Nieman MT; Trejo J
    J Biol Chem; 2016 Aug; 291(35):18453-64. PubMed ID: 27402844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.